Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Quick Byte
Resources
Search
Tuesday, June 9, 2026
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Sungrow Unveils Next-Gen Residential Energy Storage System for Reliable Home Backup…
Cosylab Introduces PlanOne™ to Advance Precision Particle Therapy Planning
Helion Secures $465 Million Series G Funding to Accelerate Commercial Fusion…
Made Scientific and Pluristyx Launch Integrated iPSC Development & Manufacturing Partnership…
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Quick Byte
Resources
Home
Tags
CB03
CB03
Biotechnology
Zhimeng Biopharma Announces Dosing of First Subject of Its Novel Antiepileptic Drug Candidate CB03 in First-in-Human Phase I Clinical Trial
PR Newswire
-
May 13, 2022
Shanghai Zhimeng Biopharma, Inc. ("Zhimeng"), announced dosing of the first participant in the US Phase I study in healthy subjects of its innovative small-molecule...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
Sungrow Unveils Next-Gen Residential Energy Storage System for Reliable Home Backup Power
Cosylab Introduces PlanOne™ to Advance Precision Particle Therapy Planning
Helion Secures $465 Million Series G Funding to Accelerate Commercial Fusion Power Plant
Load more
